BCL-G36-Anti-Rabies Monoclonal-Fujirebio-Micro

The Alabama Bureau of Clinical Laboratories is seeking to procure 800-092FUJIREBIO F.I.T.C Anti-Rabies Monoclonal Globulin, with a quantity of two units, to support laboratory testing operations. The contract emphasizes the importance of timely delivery, requiring the order to be ready for shipment within 10 business days after the purchase order is awarded, with no allowances for substitutes or alternative products. Shipping costs must be included in the order, and the items are critical for ongoing testing processes, making punctual delivery essential to avoid disruptions. The procurement process is subject to budget considerations, and the agency reserves the right to withhold award if necessary. The solicitation, identified as SRC0000029056, was posted on July 15, 2025, with responses due by July 19, 2025. The contract falls under the NAICS code 325414, which pertains to biological product manufacturing, and is managed by the Alabama state government, specifically within the Alabama Department of Public Health. The contract value is estimated to be between $5,000 and $10,000. The procurement process adheres to the State of Alabama’s standard terms and conditions for Quick Quotes, which include requirements for supplier participation, certifications, compliance with state laws, and dispute resolution procedures. The process ensures that vendors meet legal and regulatory standards, including tax exemption policies and adherence to the Beason-Hammon Alabama Taxpayer and Citizen Protection Act. More details and the procurement process can be accessed through the Alabama Buys portal.